Thu, Oct 2, 2014, 10:46 AM EDT - U.S. Markets close in 5 hrs 14 mins

Recent

% | $
Quotes you view appear here for quick access.

Cempra, Inc. Message Board

  • prpitches prpitches Feb 6, 2012 10:33 AM Flag

    Cempra Underwhelms in Nasdaq Debut

    (Chapel Hill, N.C.) Cempra (CEMP), a Chapel Hill pharmaceutical firm launched in 2006, went public on the Nasdaq late last week raising $50.4 million in an 8.4 million share offering at $6 per share, well below its target range of $11 to $13. The company, with two oral antibiotics that have completed mid-stage clinical trials, had originally hoped to raise about $72 million by selling 6 million shares.

    Shares began trading at $6.18 and hit a high of $6.58 before closing at $6.06. Cempra is the second drug developer to go public nationwide in 2012. The first therapeutic IPO, Massachusetts-based Verastem, a pre-clinical drug developer, generated much more enthusiasm in its debut one week before Cempra’s offering. The company was trading up 10 percent one week after making its debut.

    Source: http://nctechnews.com

 
CEMP
11.32-0.03(-0.22%)10:46 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.